全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...
-  2015 

芪苈强心胶囊治疗舒张性心力衰竭的疗效及安全性的Meta分析 Efficacy and Safety of Qiliqiangxin Capsule in the Treatment of Diastolic Heart Failure:A Meta Analysis

Keywords: 芪苈强心胶囊,舒张性心力衰竭,系统评价,Meta分析,随机对照试验

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:系统评价芪苈强心胶囊治疗舒张性心力衰竭的疗效及安全性。方法:计算机检索PubMed、EMbase、The Cochrane Library(2015年第3期)、CBM、CNKI、VIP和万方数据库,收集芪苈强心胶囊治疗舒张性心衰的随机对照试验(RCT)。由2位评价员分别筛选文献、提取资料和方法学质量评价后,采用RevMan 5.2软件进行Meta分析。结果:最终纳入18个RCT,共计1 404例患者。Meta分析结果显示:与对照组治疗相比,联合使用芪苈强心胶囊可以降低舒张性心衰患者血浆NT-proBNP水平,显著改善心脏舒张功能,提高临床治疗有效率和中医症候有效率,且无明显不良反应。结论:芪苈强心胶囊能够降低舒张性心衰患者血浆NT-proBNP水平,改善舒张功能,提高舒张性心衰治疗的有效率

 References

[1]  吴以岭,谷春华,徐贵成,等.芪苈强心胶囊治疗漫性心力衰竭随机双盲、多中心临床研究[J].疑难病杂志,2007,6(5):263-266.
[2]  Lee do Y,Choo BK,Yoon T,et al.Anti-inflammatory effects of Asparagus cochinchinensis extract in acute and chronic cutaneous inflammation[J].J Ethnopharmacol,2009,121:28-34.
[3]  池豪,杨东伟,刘新叶.芪苈强心胶囊联合美托洛尔治疗舒张性心功能不全的疗效观察[J].中国实用医药,2014,9(10):187-188.
[4]  黄擎轩,董辉,饶磊.芪苈强心胶囊治疗舒张性心力衰竭的疗效及机制[J].吉林医学,2013,34(22):4 469-4 470.
[5]  中华医学会心血管病学分会,《中华心血管病杂志》编辑委员会.慢性心力衰竭诊断治疗指南2007[J].中华心血管病杂志,2007,35(12):1 089-1 090.
[6]  Higgins JPT,Green S(editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[EB/OL].The Cochrane Collaboration,2011.[2011-04-01].http://www.cochrane-handbook.org.
[7]  刘鸣主编.系统评价、Meta-分析设计与实施方法[M].北京:人民卫生出版社,2011:100.
[8]  关思虞,杨玲.芪苈强心胶囊辅治射血分数正常心力衰竭的临床研究[J].疑难病杂志,2012,11(7):500-502.
[9]  冯文伟,熊斌,李玉凤.芪苈强心胶囊对射血分数保留的心力衰竭患者多普勒E/E’比值及NT-pro-BNP的影响[J].新中医,2014,46(10):39-41.
[10]  李彦霞,袁国强,贾振华.芪苈强心胶囊对舒张性心衰患者生活质量及血浆NT-proBNP水平的影响[J].中国中医基础医学杂志,2012,18(3):289-291.
[11]  共识专家组.射血分数正常心力衰竭诊治的中国专家共识[J].中国医刊,2010,45(11):63-67.
[12]  杜亚康.芪苈强心胶囊治疗舒张性心力衰竭疗效观察[J].山西中医,2014,30(2):14-15.
[13]  王华敏.芪苈强心胶囊治疗舒张性心衰的疗效分析[J].医药与保健,2014,22(2):80,86.
[14]  Gu WL,Chen CX,Wu Q,et al.Effects of chinese herb medicine radix scrophulariae on ventricular remodeling[J].Pharmazie,2010,65:770-775.
[15]  尚亚东,张家美,崔燕芪,等.苈强心胶囊治疗慢性心力衰竭的Meta分析[J].安徽医药,2013,17(11):1 949-1 953.
[16]  朱燕波,杜金行,林琳,等.明尼苏达心功能不全生命质量量表中文版的研制及临床试用[J].中华行为医学与脑科学杂志,2010,29(2):178-181.
[17]  Lisa JR,John JR,Patricia PC.Heart failure with preserved ejection fraction:an ongoing enigma[J].Cardio Clin,2014,23(1):151-161.
[18]  Zile MR.Diastolic heart failure:diagnosis,mechanisms,treatment[J].Minerva Cardioangiol,2003,51(2):131-142.
[19]  Liu W,Chen J,Xu T,et al.Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase[J].Am J Hypertens,2012,25(2):250-260.
[20]  Zou Y,Lin L,Ye Y,et al.Qiliqiangxin inhibits the development of cardiac hypertrophy,remodeling,and dysfunction during 4weeks of pressure overload in mice[J].J Cardiovasc Pharmacol,2012,59(3):268-280.
[21]  卢统庆,赵莹,孟庆鸿,等.芪苈强心胶囊辅助治疗射血分数保留的心力衰竭的临床研究[J].现代生物医学进展,2013,13(22):4 292-4 294.
[22]  孙志明.观察芪苈强心胶囊治疗舒张性心力衰50例临床疗效[J].中国医药指南,2013,11(32):199-200.
[23]  宋少飞.观察芪苈强心胶囊治疗舒张性心力衰竭的临床疗效[J].大家健康,2013,7(11):137-138.
[24]  廖国平,陈莉婧,汪铁山,等.观察芪苈强心胶囊治疗舒张性心力衰竭的临床疗效[J].中国医药指南,2013,11(23):688-689.
[25]  李彦霞,贾振华,张鑫月.芪苈强心胶囊对慢性舒张性心力衰竭患者心脏舒张功能的影响[J].疑难病杂志,2013,12(4):261-263.
[26]  李静.观察芪苈强心胶囊治疗舒张性心力衰竭的临床疗效[J].中国医药指南,2013,11(9):286-287.
[27]  甄利波,田祥.芪苈强心胶囊辅治冠心病舒张性心力衰竭效果观察[J].临床合理用药,2013,6(9):82-83.
[28]  田野,李彦霞,任君霞,等.芪苈强心胶囊治疗舒张性心衰的疗效观察[J].中国临床药理学杂志,2011,27(9):666-668.
[29]  白冬阳,白瑞莉.芪苈强心胶囊治疗舒张性心力衰竭的临床疗效[J].大家健康,2014,8(17):241.
[30]  洪恩.芪苈强心胶囊治疗舒张性心衰40例临床疗效观察[J].中国民族民间医药,2013,22(24):70.
[31]  Hamaguchi S,Kinugawa S,Sobirin MA,et al.Mode of death in patients with heart failure and reduced vs.preserved ejection fraction:report from the registry of hospitalized heart failure patients[J].Circ J,2012,76(7):1 662-1 669.
[32]  Galderisi M.Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient[J].Am J Hypertens,2011,24(5):507-517.
[33]  张秋宁,张质钢,王小虎.国内系统评价纳入标准对随机试验的界定差异有可能导致偏倚[J].中国循证医学杂志,2013,13(6):764-767.
[34]  Zile MR,Bmtsaert DL.New concepts in diastolic dysfunction and diastolic heart failure:PartI[J].Circulation,2002,105(11):1 387-1 393.
[35]  Chaeqee K.Primary diastolic heart failure[J].Am J Gefiatr Cardiol,2002,11(3):178-189.
[36]  Li X,Zhang J,Huang J,et al.A Multicenter randomized double-blind parallel-group placebo-controlled study of the effects of QiliQiangxin capsules in patients with chronic heart failure[J].J Am Coll Cardiol,2013,62(12):1 065-1 072.
[37]  Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the task force for the diagnosis and treatment of acute and chronic heart failure2008of the european society of cardiology.developed in collaboration with the heart failure association of the ESC(HFA)and endorsed by the european society of intensive care medicine(ESICM)[J].Eur Heart J,2008,29(19):2 388-2 442.
[38]  吴以岭主编.络病学[M].北京:中国中医药出版社,2006:22.
[39]  郑筱萸主编.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:88-92.
[40]  余智云.芪苈强心胶囊治疗45例舒张性心衰的临床疗效观察[J].中国民族民间医药,2013,22(21):28.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133